Interaction of enrofloxacin with breast cancer resistance protein (BCRP/ABCG2): influence of flavonoids and role in milk secretion in sheep

2006 ◽  
Vol 29 (4) ◽  
pp. 279-287 ◽  
Author(s):  
MIVIS M. PULIDO ◽  
ANTONIO J. MOLINA ◽  
GRACIA MERINO ◽  
GRACIA MENDOZA ◽  
JULIO G. PRIETO ◽  
...  
2006 ◽  
Vol 27 (4) ◽  
pp. 1247-1253 ◽  
Author(s):  
Antonius E. van Herwaarden ◽  
Els Wagenaar ◽  
Gracia Merino ◽  
Johan W. Jonker ◽  
Hilde Rosing ◽  
...  

ABSTRACT The multidrug transporter breast cancer resistance protein (BCRP/ABCG2) is strongly induced in the mammary gland during pregnancy and lactation. We here demonstrate that BCRP is responsible for pumping riboflavin (vitamin B2) into milk, thus supplying the young with this important nutrient. In Bcrp1 −/− mice, milk secretion of riboflavin was reduced >60-fold compared to that in wild-type mice. Yet, under laboratory conditions, Bcrp1 −/− pups showed no riboflavin deficiency due to concomitant milk secretion of its cofactor flavin adenine dinucleotide, which was not affected. Thus, two independent secretion mechanisms supply vitamin B2 equivalents to milk. BCRP is the first active riboflavin efflux transporter identified in mammals and the first transporter shown to concentrate a vitamin into milk. BCRP activity elsewhere in the body protects against xenotoxins by reducing their absorption and mediating their excretion. Indeed, Bcrp1 activity increased excretion of riboflavin into the intestine and decreased its systemic availability in adult mice. Surprisingly, the paradoxical dual utilization of BCRP as a xenotoxin and a riboflavin pump is evolutionarily conserved among mammals as diverse as mice and humans. This study establishes the principle that an ABC transporter can transport a vitamin into milk and raises the possibility that other vitamins and nutrients are likewise secreted into milk by ABC transporters.


2005 ◽  
Vol 67 (5) ◽  
pp. 1758-1764 ◽  
Author(s):  
Gracia Merino ◽  
Johan W. Jonker ◽  
Els Wagenaar ◽  
Antonius E. van Herwaarden ◽  
Alfred H. Schinkel

2020 ◽  
Vol 21 ◽  
Author(s):  
Sonali Mehendale-Munj

: Breast Cancer Resistance Protein (BCRP) is an efflux transporter responsible for causing multidrug re-sistance(MDR). It is known to expel many potent antineoplastic drugs, owing to its efflux function. Efflux of chemothera-peutics because of BCRP develops resistance to manydrugs, leading to failure in cancer treatment. BCRP plays an important role in physiology by protecting the organism from xenobiotics and other toxins. It is a half-transporter affiliated to theATP-binding cassette (ABC) superfamily of transporters, encoded by the gene ABCG2 and functions in response to adenosine triphosphate (ATP). Regulation of BCRP expression is critically controlled at molecular levels which help in maintaining the balance of xenobiotics and nutrients inside the body. Expression of BCRP can be found in brain, liver, lung cancers and acute myeloid leukemia (AML). Moreover, it is also expressed at high levels in stem cells and many cell lines. This frequent expression of BCRP has an impact on the treatment procedures and if not scrutinized may lead to failure of many cancer therapies.


Sign in / Sign up

Export Citation Format

Share Document